Zentalis Pharmaceuticals (ZNTL) Tax Provisions (2019 - 2026)

Zentalis Pharmaceuticals' Tax Provisions history runs 8 years deep, the most recent figure standing at $120000.0 for Q1 2026.

• In Q1 2026, Tax Provisions changed N/A year-over-year to $120000.0; the TTM figure through Mar 2026 stood at $562000.0 (up 1552.94% YoY), while the FY2025 annual figure was $442000.0, up 149.72% from the prior year.
• Tax Provisions for Q1 2026 stood at $120000.0, down from $442000.0 in the prior quarter.
• The five-year high for Tax Provisions was $442000.0 in Q4 2025, with the low at -$605000.0 in Q2 2023.
• The 5-year median for Tax Provisions is $24000.0 (2022), against an average of -$23642.9.
• The sharpest annual moves came in 2023 and 2025: Tax Provisions slumped 3658.82% in 2023, then soared 315.61% in 2025.
• Zentalis Pharmaceuticals' Tax Provisions stood at -$360000.0 in 2022, then jumped by 62.5% to -$135000.0 in 2023, then tumbled by 51.85% to -$205000.0 in 2024, then jumped by 315.61% to $442000.0 in 2025, then plunged by 72.85% to $120000.0 in 2026.
• Business Quant data shows ZNTL's Tax Provisions at $120000.0 in Q1 2026, $442000.0 in Q4 2025, and -$205000.0 in Q4 2024.